List of Tables
Table 1. Global Parkinson Disease Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson Disease Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Parkinson Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Parkinson Disease Drug Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Parkinson Disease Drug Market Share by Region (2019-2024)
Table 11. Global Parkinson Disease Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Parkinson Disease Drug Market Share by Region (2025-2030)
Table 13. Parkinson Disease Drug Market Trends
Table 14. Parkinson Disease Drug Market Drivers
Table 15. Parkinson Disease Drug Market Challenges
Table 16. Parkinson Disease Drug Market Restraints
Table 17. Global Parkinson Disease Drug Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Parkinson Disease Drug Market Share by Players (2019-2024)
Table 19. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2023)
Table 20. Ranking of Global Top Parkinson Disease Drug Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Parkinson Disease Drug Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Parkinson Disease Drug Product Solution and Service
Table 24. Date of Enter into Parkinson Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson Disease Drug Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Parkinson Disease Drug Revenue Market Share by Type (2019-2024)
Table 28. Global Parkinson Disease Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Parkinson Disease Drug Revenue Market Share by Type (2025-2030)
Table 30. Global Parkinson Disease Drug Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Parkinson Disease Drug Revenue Market Share by Application (2019-2024)
Table 32. Global Parkinson Disease Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Parkinson Disease Drug Revenue Market Share by Application (2025-2030)
Table 34. North America Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Parkinson Disease Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Parkinson Disease Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Parkinson Disease Drug Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Parkinson Disease Drug Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Parkinson Disease Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Parkinson Disease Drug Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Parkinson Disease Drug Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Parkinson Disease Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Parkinson Disease Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Parkinson Disease Drug Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Parkinson Disease Drug Market Size by Country (2025-2030) & (US$ Million)
Table 49. Merck Company Detail
Table 50. Merck Business Overview
Table 51. Merck Parkinson Disease Drug Product
Table 52. Merck Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Akorn Company Detail
Table 55. Akorn Business Overview
Table 56. Akorn Parkinson Disease Drug Product
Table 57. Akorn Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 58. Akorn Recent Development
Table 59. GSK Company Detail
Table 60. GSK Business Overview
Table 61. GSK Parkinson Disease Drug Product
Table 62. GSK Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Parkinson Disease Drug Product
Table 67. Novartis Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Boehringer Ingelheim Company Detail
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Parkinson Disease Drug Product
Table 72. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 73. Boehringer Ingelheim Recent Development
Table 74. Teva Pharmaceutical Company Detail
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Parkinson Disease Drug Product
Table 77. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Abbvie Company Detail
Table 80. Abbvie Business Overview
Table 81. Abbvie Parkinson Disease Drug Product
Table 82. Abbvie Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 83. Abbvie Recent Development
Table 84. Kyowa Hakko Kirin Pharma Company Detail
Table 85. Kyowa Hakko Kirin Pharma Business Overview
Table 86. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product
Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 88. Kyowa Hakko Kirin Pharma Recent Development
Table 89. Astellas Pharma Company Detail
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Parkinson Disease Drug Product
Table 92. Astellas Pharma Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 93. Astellas Pharma Recent Development
Table 94. Desitin Arzneimittel Company Detail
Table 95. Desitin Arzneimittel Business Overview
Table 96. Desitin Arzneimittel Parkinson Disease Drug Product
Table 97. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 98. Desitin Arzneimittel Recent Development
Table 99. Endo Pharmaceuticals Company Detail
Table 100. Endo Pharmaceuticals Business Overview
Table 101. Endo Pharmaceuticals Parkinson Disease Drug Product
Table 102. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 103. Endo Pharmaceuticals Recent Development
Table 104. F.Hoffmann-La Roche Company Detail
Table 105. F.Hoffmann-La Roche Business Overview
Table 106. F.Hoffmann-La Roche Parkinson Disease Drug Product
Table 107. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 108. F.Hoffmann-La Roche Recent Development
Table 109. H.Lundbeck Company Detail
Table 110. H.Lundbeck Business Overview
Table 111. H.Lundbeck Parkinson Disease Drug Product
Table 112. H.Lundbeck Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 113. H.Lundbeck Recent Development
Table 114. Valeant Company Detail
Table 115. Valeant Business Overview
Table 116. Valeant Parkinson Disease Drug Product
Table 117. Valeant Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 118. Valeant Recent Development
Table 119. Apokyn Company Detail
Table 120. Apokyn Business Overview
Table 121. Apokyn Parkinson Disease Drug Product
Table 122. Apokyn Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 123. Apokyn Recent Development
Table 124. Orion Company Detail
Table 125. Orion Business Overview
Table 126. Orion Parkinson Disease Drug Product
Table 127. Orion Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 128. Orion Recent Development
Table 129. Stada Arzneimittel Company Detail
Table 130. Stada Arzneimittel Business Overview
Table 131. Stada Arzneimittel Parkinson Disease Drug Product
Table 132. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 133. Stada Arzneimittel Recent Development
Table 134. US WorldMeds Company Detail
Table 135. US WorldMeds Business Overview
Table 136. US WorldMeds Parkinson Disease Drug Product
Table 137. US WorldMeds Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 138. US WorldMeds Recent Development
Table 139. Bausch Health Company Detail
Table 140. Bausch Health Business Overview
Table 141. Bausch Health Parkinson Disease Drug Product
Table 142. Bausch Health Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
Table 143. Bausch Health Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson Disease Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Parkinson Disease Drug Market Share by Type: 2023 VS 2030
Figure 3. Sinemet-CR Features
Figure 4. Trastal Features
Figure 5. Madopar Features
Figure 6. COMT Inhibitor Features
Figure 7. Other Features
Figure 8. Global Parkinson Disease Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Parkinson Disease Drug Market Share by Application: 2023 VS 2030
Figure 10. Under 40 Years Old Case Studies
Figure 11. 40-65 Years Old Case Studies
Figure 12. Above 65 Years Old Case Studies
Figure 13. Parkinson Disease Drug Report Years Considered
Figure 14. Global Parkinson Disease Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Parkinson Disease Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Parkinson Disease Drug Market Share by Region: 2023 VS 2030
Figure 17. Global Parkinson Disease Drug Market Share by Players in 2023
Figure 18. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Parkinson Disease Drug Revenue in 2023
Figure 20. North America Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Parkinson Disease Drug Market Share by Country (2019-2030)
Figure 22. United States Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Parkinson Disease Drug Market Share by Country (2019-2030)
Figure 26. Germany Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Parkinson Disease Drug Market Share by Region (2019-2030)
Figure 34. China Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Parkinson Disease Drug Market Share by Country (2019-2030)
Figure 42. Mexico Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Parkinson Disease Drug Market Share by Country (2019-2030)
Figure 46. Turkey Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 49. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 50. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 53. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 54. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 55. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 56. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 57. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 58. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 59. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 60. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 61. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 62. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 63. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 64. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 65. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 66. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed